Global Transdermal Therapeutic Systems TTS Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146277
- Pages: 250
-
Format:
Report Overview
Transdermal Therapeutic Systems (TTS) is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
Prudent Markets latest report provides a deep insight into the global Transdermal Therapeutic Systems TTS market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transdermal Therapeutic Systems TTS Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transdermal Therapeutic Systems TTS market in any manner.
Global Transdermal Therapeutic Systems TTS Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Nitto Denko
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Pfizer
Bayer
Lingrui
Sanofi
UCB Pharma
Dr. Reddy's Laboratories
Qizheng
Endo
Mundipharma
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Beijing Tide Pharmaceutical
Luye Pharma Group
Market Segmentation (by Type)
Methyl Salicylate
Nitroglycerin
Fentanyl
Nicotine
Rivastigmine
Estradiol
Others
Market Segmentation (by Application)
OTC Channel
Retail Channel
E-Commerce Channel
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Transdermal Therapeutic Systems TTS Market
Overview of the regional outlook of the Transdermal Therapeutic Systems TTS Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Transdermal Therapeutic Systems TTS Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Transdermal Therapeutic Systems TTS
1.2 Key Market Segments
1.2.1 Transdermal Therapeutic Systems TTS Segment by Type
1.2.2 Transdermal Therapeutic Systems TTS Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Transdermal Therapeutic Systems TTS Market Overview
2.1 Global Market Overview
2.1.1 Global Transdermal Therapeutic Systems TTS Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Transdermal Therapeutic Systems TTS Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Transdermal Therapeutic Systems TTS Market Competitive Landscape
3.1 Global Transdermal Therapeutic Systems TTS Sales by Manufacturers (2018-2023)
3.2 Global Transdermal Therapeutic Systems TTS Revenue Market Share by Manufacturers (2018-2023)
3.3 Transdermal Therapeutic Systems TTS Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transdermal Therapeutic Systems TTS Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Transdermal Therapeutic Systems TTS Sales Sites, Area Served, Product Type
3.6 Transdermal Therapeutic Systems TTS Market Competitive Situation and Trends
3.6.1 Transdermal Therapeutic Systems TTS Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transdermal Therapeutic Systems TTS Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Transdermal Therapeutic Systems TTS Industry Chain Analysis
4.1 Transdermal Therapeutic Systems TTS Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Transdermal Therapeutic Systems TTS Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Transdermal Therapeutic Systems TTS Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transdermal Therapeutic Systems TTS Sales Market Share by Type (2018-2023)
6.3 Global Transdermal Therapeutic Systems TTS Market Size Market Share by Type (2018-2023)
6.4 Global Transdermal Therapeutic Systems TTS Price by Type (2018-2023)
7 Transdermal Therapeutic Systems TTS Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transdermal Therapeutic Systems TTS Market Sales by Application (2018-2023)
7.3 Global Transdermal Therapeutic Systems TTS Market Size (M USD) by Application (2018-2023)
7.4 Global Transdermal Therapeutic Systems TTS Sales Growth Rate by Application (2018-2023)
8 Transdermal Therapeutic Systems TTS Market Segmentation by Region
8.1 Global Transdermal Therapeutic Systems TTS Sales by Region
8.1.1 Global Transdermal Therapeutic Systems TTS Sales by Region
8.1.2 Global Transdermal Therapeutic Systems TTS Sales Market Share by Region
8.2 North America
8.2.1 North America Transdermal Therapeutic Systems TTS Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transdermal Therapeutic Systems TTS Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transdermal Therapeutic Systems TTS Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transdermal Therapeutic Systems TTS Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transdermal Therapeutic Systems TTS Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hisamitsu
9.1.1 Hisamitsu Transdermal Therapeutic Systems TTS Basic Information
9.1.2 Hisamitsu Transdermal Therapeutic Systems TTS Product Overview
9.1.3 Hisamitsu Transdermal Therapeutic Systems TTS Product Market Performance
9.1.4 Hisamitsu Business Overview
9.1.5 Hisamitsu Transdermal Therapeutic Systems TTS SWOT Analysis
9.1.6 Hisamitsu Recent Developments
9.2 Mylan
9.2.1 Mylan Transdermal Therapeutic Systems TTS Basic Information
9.2.2 Mylan Transdermal Therapeutic Systems TTS Product Overview
9.2.3 Mylan Transdermal Therapeutic Systems TTS Product Market Performance
9.2.4 Mylan Business Overview
9.2.5 Mylan Transdermal Therapeutic Systems TTS SWOT Analysis
9.2.6 Mylan Recent Developments
9.3 GSK
9.3.1 GSK Transdermal Therapeutic Systems TTS Basic Information
9.3.2 GSK Transdermal Therapeutic Systems TTS Product Overview
9.3.3 GSK Transdermal Therapeutic Systems TTS Product Market Performance
9.3.4 GSK Business Overview
9.3.5 GSK Transdermal Therapeutic Systems TTS SWOT Analysis
9.3.6 GSK Recent Developments
9.4 Novartis
9.4.1 Novartis Transdermal Therapeutic Systems TTS Basic Information
9.4.2 Novartis Transdermal Therapeutic Systems TTS Product Overview
9.4.3 Novartis Transdermal Therapeutic Systems TTS Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Transdermal Therapeutic Systems TTS SWOT Analysis
9.4.6 Novartis Recent Developments
9.5 Teve (Actavis)
9.5.1 Teve (Actavis) Transdermal Therapeutic Systems TTS Basic Information
9.5.2 Teve (Actavis) Transdermal Therapeutic Systems TTS Product Overview
9.5.3 Teve (Actavis) Transdermal Therapeutic Systems TTS Product Market Performance
9.5.4 Teve (Actavis) Business Overview
9.5.5 Teve (Actavis) Transdermal Therapeutic Systems TTS SWOT Analysis
9.5.6 Teve (Actavis) Recent Developments
9.6 Nitto Denko
9.6.1 Nitto Denko Transdermal Therapeutic Systems TTS Basic Information
9.6.2 Nitto Denko Transdermal Therapeutic Systems TTS Product Overview
9.6.3 Nitto Denko Transdermal Therapeutic Systems TTS Product Market Performance
9.6.4 Nitto Denko Business Overview
9.6.5 Nitto Denko Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Transdermal Therapeutic Systems TTS Basic Information
9.7.2 Johnson and Johnson Transdermal Therapeutic Systems TTS Product Overview
9.7.3 Johnson and Johnson Transdermal Therapeutic Systems TTS Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Lohmann
9.8.1 Lohmann Transdermal Therapeutic Systems TTS Basic Information
9.8.2 Lohmann Transdermal Therapeutic Systems TTS Product Overview
9.8.3 Lohmann Transdermal Therapeutic Systems TTS Product Market Performance
9.8.4 Lohmann Business Overview
9.8.5 Lohmann Recent Developments
9.9 Teikoku Seiyaku
9.9.1 Teikoku Seiyaku Transdermal Therapeutic Systems TTS Basic Information
9.9.2 Teikoku Seiyaku Transdermal Therapeutic Systems TTS Product Overview
9.9.3 Teikoku Seiyaku Transdermal Therapeutic Systems TTS Product Market Performance
9.9.4 Teikoku Seiyaku Business Overview
9.9.5 Teikoku Seiyaku Recent Developments
9.10 Pfizer
9.10.1 Pfizer Transdermal Therapeutic Systems TTS Basic Information
9.10.2 Pfizer Transdermal Therapeutic Systems TTS Product Overview
9.10.3 Pfizer Transdermal Therapeutic Systems TTS Product Market Performance
9.10.4 Pfizer Business Overview
9.10.5 Pfizer Recent Developments
9.11 Bayer
9.11.1 Bayer Transdermal Therapeutic Systems TTS Basic Information
9.11.2 Bayer Transdermal Therapeutic Systems TTS Product Overview
9.11.3 Bayer Transdermal Therapeutic Systems TTS Product Market Performance
9.11.4 Bayer Business Overview
9.11.5 Bayer Recent Developments
9.12 Lingrui
9.12.1 Lingrui Transdermal Therapeutic Systems TTS Basic Information
9.12.2 Lingrui Transdermal Therapeutic Systems TTS Product Overview
9.12.3 Lingrui Transdermal Therapeutic Systems TTS Product Market Performance
9.12.4 Lingrui Business Overview
9.12.5 Lingrui Recent Developments
9.13 Sanofi
9.13.1 Sanofi Transdermal Therapeutic Systems TTS Basic Information
9.13.2 Sanofi Transdermal Therapeutic Systems TTS Product Overview
9.13.3 Sanofi Transdermal Therapeutic Systems TTS Product Market Performance
9.13.4 Sanofi Business Overview
9.13.5 Sanofi Recent Developments
9.14 UCB Pharma
9.14.1 UCB Pharma Transdermal Therapeutic Systems TTS Basic Information
9.14.2 UCB Pharma Transdermal Therapeutic Systems TTS Product Overview
9.14.3 UCB Pharma Transdermal Therapeutic Systems TTS Product Market Performance
9.14.4 UCB Pharma Business Overview
9.14.5 UCB Pharma Recent Developments
9.15 Dr. Reddy's Laboratories
9.15.1 Dr. Reddy's Laboratories Transdermal Therapeutic Systems TTS Basic Information
9.15.2 Dr. Reddy's Laboratories Transdermal Therapeutic Systems TTS Product Overview
9.15.3 Dr. Reddy's Laboratories Transdermal Therapeutic Systems TTS Product Market Performance
9.15.4 Dr. Reddy's Laboratories Business Overview
9.15.5 Dr. Reddy's Laboratories Recent Developments
9.16 Qizheng
9.16.1 Qizheng Transdermal Therapeutic Systems TTS Basic Information
9.16.2 Qizheng Transdermal Therapeutic Systems TTS Product Overview
9.16.3 Qizheng Transdermal Therapeutic Systems TTS Product Market Performance
9.16.4 Qizheng Business Overview
9.16.5 Qizheng Recent Developments
9.17 Endo
9.17.1 Endo Transdermal Therapeutic Systems TTS Basic Information
9.17.2 Endo Transdermal Therapeutic Systems TTS Product Overview
9.17.3 Endo Transdermal Therapeutic Systems TTS Product Market Performance
9.17.4 Endo Business Overview
9.17.5 Endo Recent Developments
9.18 Mundipharma
9.18.1 Mundipharma Transdermal Therapeutic Systems TTS Basic Information
9.18.2 Mundipharma Transdermal Therapeutic Systems TTS Product Overview
9.18.3 Mundipharma Transdermal Therapeutic Systems TTS Product Market Performance
9.18.4 Mundipharma Business Overview
9.18.5 Mundipharma Recent Developments
9.19 Huarun 999
9.19.1 Huarun 999 Transdermal Therapeutic Systems TTS Basic Information
9.19.2 Huarun 999 Transdermal Therapeutic Systems TTS Product Overview
9.19.3 Huarun 999 Transdermal Therapeutic Systems TTS Product Market Performance
9.19.4 Huarun 999 Business Overview
9.19.5 Huarun 999 Recent Developments
9.20 Haw Par
9.20.1 Haw Par Transdermal Therapeutic Systems TTS Basic Information
9.20.2 Haw Par Transdermal Therapeutic Systems TTS Product Overview
9.20.3 Haw Par Transdermal Therapeutic Systems TTS Product Market Performance
9.20.4 Haw Par Business Overview
9.20.5 Haw Par Recent Developments
9.21 Nichiban
9.21.1 Nichiban Transdermal Therapeutic Systems TTS Basic Information
9.21.2 Nichiban Transdermal Therapeutic Systems TTS Product Overview
9.21.3 Nichiban Transdermal Therapeutic Systems TTS Product Market Performance
9.21.4 Nichiban Business Overview
9.21.5 Nichiban Recent Developments
9.22 Mentholatum Company
9.22.1 Mentholatum Company Transdermal Therapeutic Systems TTS Basic Information
9.22.2 Mentholatum Company Transdermal Therapeutic Systems TTS Product Overview
9.22.3 Mentholatum Company Transdermal Therapeutic Systems TTS Product Market Performance
9.22.4 Mentholatum Company Business Overview
9.22.5 Mentholatum Company Recent Developments
9.23 Laboratoires Genevrier
9.23.1 Laboratoires Genevrier Transdermal Therapeutic Systems TTS Basic Information
9.23.2 Laboratoires Genevrier Transdermal Therapeutic Systems TTS Product Overview
9.23.3 Laboratoires Genevrier Transdermal Therapeutic Systems TTS Product Market Performance
9.23.4 Laboratoires Genevrier Business Overview
9.23.5 Laboratoires Genevrier Recent Developments
9.24 Beijing Tide Pharmaceutical
9.24.1 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems TTS Basic Information
9.24.2 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems TTS Product Overview
9.24.3 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems TTS Product Market Performance
9.24.4 Beijing Tide Pharmaceutical Business Overview
9.24.5 Beijing Tide Pharmaceutical Recent Developments
9.25 Luye Pharma Group
9.25.1 Luye Pharma Group Transdermal Therapeutic Systems TTS Basic Information
9.25.2 Luye Pharma Group Transdermal Therapeutic Systems TTS Product Overview
9.25.3 Luye Pharma Group Transdermal Therapeutic Systems TTS Product Market Performance
9.25.4 Luye Pharma Group Business Overview
9.25.5 Luye Pharma Group Recent Developments
10 Transdermal Therapeutic Systems TTS Market Forecast by Region
10.1 Global Transdermal Therapeutic Systems TTS Market Size Forecast
10.2 Global Transdermal Therapeutic Systems TTS Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transdermal Therapeutic Systems TTS Market Size Forecast by Country
10.2.3 Asia Pacific Transdermal Therapeutic Systems TTS Market Size Forecast by Region
10.2.4 South America Transdermal Therapeutic Systems TTS Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transdermal Therapeutic Systems TTS by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Transdermal Therapeutic Systems TTS Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Transdermal Therapeutic Systems TTS by Type (2024-2029)
11.1.2 Global Transdermal Therapeutic Systems TTS Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Transdermal Therapeutic Systems TTS by Type (2024-2029)
11.2 Global Transdermal Therapeutic Systems TTS Market Forecast by Application (2024-2029)
11.2.1 Global Transdermal Therapeutic Systems TTS Sales (K MT) Forecast by Application
11.2.2 Global Transdermal Therapeutic Systems TTS Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
